Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer. Jiang Y, Wang J, Jiang P, Wang X, et al. BMC Cancer 2023;23:481.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jiang Y, Wang J, Jiang P, Wang X, et al. Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer. BMC Cancer 2023;23:481.
PMID: 37245053